He further alleged that some PCN officials were involved in clandestine pharmaceutical businesses.
However, the council rejected the allegations, maintaining that the regulation and registration of pharmaceutical premises fell within its statutory responsibilities under the Pharmacy Council of Nigeria (Establishment) Act 2022.
On the disputed Apple Avenue premises, the PCN argued that its regulations did not prohibit the registration of pharmaceutical outlets in residential areas, provided they met the necessary requirements.
It challenged Magaji to identify the specific provisions of the Land Use Act allegedly violated by the registration of the premises.
The council said, “The registration of pharmaceutical premises is a statutory responsibility of the Pharmacy Council of Nigeria, as provided for under the Pharmacy Council of Nigeria (Establishment) Act 2022.”
It also clarified the respective responsibilities of the PCN and NAFDAC regarding pharmaceutical imports, explaining that it issued import licences to pharmaceutical companies, while NAFDAC issued product permits specifying the categories and quantities of medicines authorised for importation.
Addressing concerns about its enforcement capacity, the council said the number of its permanent personnel in Kano did not determine its ability to discharge its regulatory responsibilities.
It explained that its regulatory structure involved state-level committees chaired by Directors of Pharmaceutical Services in the respective state ministries of health, with PCN officers and other appointed pharmacists participating in inspection activities.
The council disclosed that its national enforcement team had visited 11 states in 2026, including Kano, where operations were conducted in April and September.
According to the statement, 9,908 pharmaceutical outlets were inspected across the 11 states, with 6,838 sealed for various regulatory violations.
In Kano State alone, the council said 2,304 outlets were inspected, 1,631 sealed, while investigations involving 15 premises were ongoing.
The PCN clarified that the figures did not include routine enforcement operations conducted by its Kano State office.
On the Federal Government’s Coordinated Wholesale Centre initiative, the council said the programme was designed to relocate identified and verified pharmaceutical vendors from open drug markets, including Sabon Gari, rather than prevent independent wholesalers, distributors and importers from establishing separate facilities.
The council further challenged the task force chairman to provide specific evidence of alleged misconduct involving its personnel, promising to investigate any credible complaint submitted against its officers.
It said, “Any allegation of misconduct against any officer of the Council should be supported with verifiable evidence and submitted through the appropriate channels for necessary investigation and action.”
The PCN warned against making sweeping allegations against public institutions without supporting evidence, arguing that such claims could undermine the work of agencies responsible for regulating medicines and protecting public health.
It reaffirmed its commitment to tackling the unauthorised distribution of controlled medicines and urged members of the public and relevant organisations to report suspected violations through its established channels.
The dispute comes amid intensified efforts by Kano authorities to tackle drug abuse and illicit pharmaceutical distribution, particularly the circulation of pregabalin, which the state task force has identified as a major concern.
The task force had earlier disclosed that it arrested 1,760 suspects and secured 890 convictions in drug-related cases, with 63 cases pending before the courts. It also reported seizing 3.18 million pregabalin capsules.






